Skip to main content

Use of microbiome for machine learning-based early prediction of colorrectal cancer in populational

FJC2021-046546-I

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprogram Subprograma Estatal de Formación
Call Juan de la Cierva Formación
Call year 2021
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD, M.P.

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

The integrated genomic surveillance system of Andalusia (SIEGA) provides a One Health regional resource connected with the clinic

  • Casimiro Soriguer, Carlos S.
  • Perez Florido, Javier
  • Robles, Enrique
  • Lara, María
  • Aguado, Andrea
  • Rodríguez Iglesias, Manuel Antonio
  • Lepe, Jose A.
  • García, Federico
  • Pérez Alegre, Mónica
  • Andújar, Eloísa
  • Jiménez, Victoria E.
  • Camino, Lola P.
  • Loruso, Nicola
  • Ameyugo, Ulises
  • Vazquez, Isabel María
  • Lozano, Carlota M.
  • Chaves, J. Alberto
  • Dopazo, Joaquín
The One Health approach, recognizing the interconnectedness of human, animal, and environmental health, has gained significance amid emerging zoonotic diseases and antibiotic resistance concerns. This paper aims to demonstrate the utility of a collaborative tool, the SIEGA, for monitoring infectious diseases across domains, fostering a comprehensive understanding of disease dynamics and risk factors, highlighting the pivotal role of One Health surveillance systems. Raw whole-genome sequencing is processed through different species-specific open software that additionally reports the presence of genes associated to anti-microbial resistances and virulence. The SIEGA application is a Laboratory Information Management System, that allows customizing reports, detect transmission chains, and promptly alert on alarming genetic similarities. The SIEGA initiative has successfully accumulated a comprehensive collection of more than 1900 bacterial genomes, including Salmonella enterica, Listeria monocytogenes, Campylobacter jejuni, Escherichia coli, Yersinia enterocolitica and Legionella pneumophila, showcasing its potential in monitoring pathogen transmission, resistance patterns, and virulence factors. SIEGA enables customizable reports and prompt detection of transmission chains, highlighting its contribution to enhancing vigilance and response capabilities. Here we show the potential of genomics in One Health surveillance when supported by an appropriate bioinformatic tool. By facilitating precise disease control strategies and antimicrobial resistance management, SIEGA enhances global health security and reduces the burden of infectious diseases. The integration of health data from humans, animals, and the environment, coupled with advanced genomics, underscores the importance of a holistic One Health approach in mitigating health threats.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Molecular and phylogenetic characterization of the monkeypox outbreak in the South of Spain

  • Casimiro-Soriguer, Carlos S.
  • Pérez-Florido, Javier
  • Lara, María
  • Camacho‐Martínez, Pedro
  • Merino Díaz, Laura
  • Pupo Ledo, María Inmaculada
  • Salazar, Adolfo de
  • Fuentes, Ana
  • Viñuela, Laura
  • Chueca, Natalia
  • Martínez-Martínez, Luis
  • Lorusso, Nicola
  • Andalusian Genomic Surveillance Network
  • Lepe, José A.
  • Dopazo, Joaquín
  • García, Federico
Until the May 2022 Monkeypox outbreak, which spread rapidly to many non-endemic countries, the virus was considered a viral zoonosis limited to some African countries. The Andalusian circuit of genomic surveillance was rapidly applied to characterize the Monkeypox outbreak in the South of Spain. Whole genome sequencing was used to obtain the genomic profiles of samples collected across the south of Spain, representative of all the provinces of Andalusia. Phylogenetic analysis was used to study the relationship of the isolates and the available sequences of the 2022 outbreak. Whole genome sequencing of a total of 160 monkeypox viruses from the different provinces that reported cases were obtained. Interestingly, we report the sequences of monkeypox viruses obtained from two patients who died. While one of the isolates bore no noteworthy mutations that explain a potential heightened virulence, in another patient the second consecutive genome sequence, performed after the administration of tecovirimat, uncovered a mutation within the A0A7H0DN30 gene, known to be a prime target for tecovirimat in its Vaccinia counterpart. In general, a low number of mutations were observed in the sequences reported, which were very similar to the reference of the 2022 outbreak (OX044336), as expected from a DNA virus. The samples likely correspond to several introductions of the circulating monkeypox viruses from the last outbreak. The virus sequenced from one of the two patients that died presented a mutation in a gene that bears potential connections to drug resistance. This mutation was absent in the initial sequencing prior to treatment, This work was supported by Spanish Ministry of Science and Innovation (grants PID2020- 117979RB-I00 and FJC2021-046546-I), the Instituto de Salud Carlos III (ISCIII), co-funded with European Regional Development Funds (ERDF) (grant IMP/00019), it has also been funded by Consejería de Salud y Consumo, Junta de Andalucía (grants COVID-0012-2020), and by grant ELIXIR-CONVERGE - Connect and align ELIXIR Nodes to deliver sustainable FAIR lifescience data management services (AMD-871075-16), funded by EU – H2020., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The integrated genomic surveillance system of Andalusia (SIEGA) provides a One Health regional resource connected with the clinic

  • Casimiro-Soriguer, Carlos S.
  • Pérez-Florido, Javier
  • Robles, Enrique A.
  • Lara, María
  • Aguado, Andrea
  • Rodríguez Iglesias, Manuel A.
  • Lepe, José A.
  • García, Federico
  • Pérez-Alegre, Mónica
  • Andújar, Eloísa
  • Jiménez, Victoria E.
  • Camino, Lola P.
  • Loruso, Nicola
  • Ameyugo, Ulises
  • Vazquez, Isabel María
  • Lozano, Carlota M.
  • Chaves, J. Alberto
  • Dopazo, Joaquín
The One Health approach, recognizing the interconnectedness of human, animal, and environmental health, has gained significance amid emerging zoonotic diseases and antibiotic resistance concerns. This paper aims to demonstrate the utility of a collaborative tool, the SIEGA, for monitoring infectious diseases across domains, fostering a comprehensive understanding of disease dynamics and risk factors, highlighting the pivotal role of One Health surveillance systems. Raw whole-genome sequencing is processed through different species-specific open software that additionally reports the presence of genes associated to anti-microbial resistances and virulence. The SIEGA application is a Laboratory Information Management System, that allows customizing reports, detect transmission chains, and promptly alert on alarming genetic similarities. The SIEGA initiative has successfully accumulated a comprehensive collection of more than 1900 bacterial genomes, including Salmonella enterica, Listeria monocytogenes, Campylobacter jejuni, Escherichia coli, Yersinia enterocolitica and Legionella pneumophila, showcasing its potential in monitoring pathogen transmission, resistance patterns, and virulence factors. SIEGA enables customizable reports and prompt detection of transmission chains, highlighting its contribution to enhancing vigilance and response capabilities. Here we show the potential of genomics in One Health surveillance when supported by an appropriate bioinformatic tool. By facilitating precise disease control strategies and antimicrobial resistance management, SIEGA enhances global health security and reduces the burden of infectious diseases. The integration of health data from humans, animals, and the environment, coupled with advanced genomics, underscores the importance of a holistic One Health approach in mitigating health threats., This work was supported by the Instituto de Salud Carlos III (ISCIII), co-funded with European Regional Development Funds (ERDF) (Grant IMP/00019), it has also been funded by Consejería de Salud y Consumo, Junta de Andalucía (Grants COVID-0012-2020, PIP-0087-2021), and by grant ELIXIR-CONVERGE—Connect and align ELIXIR Nodes to deliver sustainable FAIR lifescience data management services (AMD-871075-16), funded by EU – H2020. CSCS was funded by a Juan de la Cierva Grant (FJC2021-046546-I) from Ministerio de Ciencia e Innovación., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Molecular and phylogenetic characterization of the monkeypox outbreak in the South of Spain

  • Casimiro-Soriguer, Carlos S.
  • Pérez-Florido, Javier
  • Lara, María
  • Camacho‐Martínez, Pedro
  • Merino Díaz, Laura
  • Pupo Ledo, María Inmaculada
  • de Salazar, Adolfo
  • Fuentes, Ana
  • Viñuela, Laura
  • Chueca, Natalia
  • Martínez-Martínez, Luis
  • Lorusso, Nicola
  • Lepe, José A.
  • Dopazo, Joaquín
  • García, Federico
[Background and Aim] Until the May 2022 Monkeypox (MPXV) outbreak, which spread rapidly to many non-endemic countries, the virus was considered a viral zoonosis limited to some African countries. The Andalusian circuit of genomic surveillance was rapidly applied to characterize the MPXV outbreak in the South of Spain., [Methods] Whole genome sequencing was used to obtain the genomic profiles of samples collected across the south of Spain, representative of all the provinces of Andalusia. Phylogenetic analysis was used to study the relationship of the isolates and the available sequences of the 2022 outbreak., [Results] Whole genome sequencing of a total of 160 MPXV viruses from the different provinces that reported cases were obtained. Interestingly, we report the sequences of MPXV viruses obtained from two patients who died. While one of the isolates bore no noteworthy mutations that explain a potential heightened virulence, in another patient the second consecutive genome sequence, performed after the administration of tecovirimat, uncovered a mutation within the A0A7H0DN30 gene, known to be a prime target for tecovirimat in its Vaccinia counterpart. In general, a low number of mutations were observed in the sequences reported, which were very similar to the reference of the 2022 outbreak (OX044336), as expected from a DNA virus. The samples likely correspond to several introductions of the circulating MPXV viruses from the last outbreak. The virus sequenced from one of the two patients that died presented a mutation in a gene that bears potential connections to drug resistance. This mutation was absent in the initial sequencing before treatment., This work was supported by Spanish Ministry of Science and Innovation (grants PID2020-117979RB-I00 and FJC2021-046546-I), the Instituto de Salud Carlos III (ISCIII), cofunded with European Regional Development Funds (ERDF) (grant IMP/00019), it has also been funded by Consejería de Salud y Consumo, Junta de Andalucía (grants COVID-0012-2020), and by grant ELIXIR-CONVERGE-Connect and align ELIXIR Nodes to deliver sustainable FAIR lifescience data management services (AMD-871075-16), funded by EU–H2020., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Survival of infection with TEM β-lactamase-producing Escherichia coli with Pan-β-lactam resistance

  • Rodríguez-Villodres, Ángel
  • Ortiz de la Rosa, José Manuel
  • Gálvez-Benítez, Lydia
  • Gascón, María Luisa
  • Peñalva, Germán
  • Dorado Pardo, Francisco J.
  • Casimiro-Soriguer, Carlos S.
  • Rodríguez Rodríguez, Marta
  • Amaya Villar, Rosario
  • Cisneros, José Miguel
  • Lepe, José A.
Antimicrobial resistance is a critical global health issue, significantly contributing to patient mortality. Recent antibiotic developments have aimed to counteract carbapenemase-producing Enterobacterales; however, the impact of their use on the emergence of antibiotic resistance is unknown. This study investigates the first case of a non-carbapenemase-producing, pan-β-lactam-resistant Escherichia coli strain from a patient previously treated with ceftolozane-tazobactam and cefiderocol., This work was funded by the Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, and co-financed by the European Union (grant PI22/001464). A.R.V. is supported by the Subprograma Juan Rodés, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spain, and co-funded by de European Union (JR20/00023). J.M.O.R. is supported by the Subprograma Sara Borrell, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spain, co-funded by the European Union (CD21/00098). L.G.B. is supported by the Subprograma Rio Hortega, Instituto Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spain, co-funded by the European Union (CM22/00196). G.P. is supported by grant PMP22/00092, Centro de Investigación Biomédica en Red (CIBER), Madrid, Spain. C.S.C-S is supported by a Grant FJC2021–046546-I funded by MICIU/AEI/10.13039/501100011033 and, as appropriate, by “ESF Investing in your future”, by “ESF+” or by “European Union NextGenerationEU/PRTR., Peer reviewed